Oktober 2021: Cabozantinib (Cabometyx, Exelixis, Inc.) parantos disatujuan ku Administrasi Pangan sareng Narkoba pikeun penderita dewasa sareng murangkalih umur 12 taun sareng langkung lami anu ngagaduhan thyroi diferensiasi sacara lokal atanapi metastatik.
Lenvatinib (Lenvima) New oral anticancer drug Lenvima (lenvatinib) has recently been approved by Japan for the treatment of unresectable thyroid cancer. This is another important market that the drug has captured since it was app..